| 
      *P<0.05 vs. intact control (Group I)
        | Treatment | Blood Glucose, mM |  
        | Onset    of Experiment | End of    Experiment |  
        | Group I (untreated control)
 | 5,7 ±    0.31 | 5.9 ±    0.42 |  
        | Group    II (STZ)
 | 5.8 ±    0.32 | 14.6 ±    2.40* |  
        | Group    III (C60HyFn control)
 | 5.6 ±    0.30 | 5.5 ±    0.19 |  
        | Group    IV (C60HyFn prophylactic regime + STZ)
 | 5.3 ±    0.42 | 13.8 ±    1.70* |  
        | Group V (STZ + C60HyFn therapeutic regime)
 | 6.1 ±    0.53 | 15.1 ±    2.21* |  |